BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
ZBTB7A
,
calcium channel activity
,
Lung cancer
,
Retina
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
protein kinase RNA- activated
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RN…
dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.
Multiple levels of PKR inhibition during HIV-1 replication.
The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein …
Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-de…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell…
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally…
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ